Cargando…

Biomarkers in DILI: One More Step Forward

Despite being relatively rare, drug-induced liver injury (DILI) is a serious condition, both for the individual patient due to the risk of acute liver failure, and for the drug development industry and regulatory agencies due to associations with drug development attritions, black box warnings, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Robles-Díaz, Mercedes, Medina-Caliz, Inmaculada, Stephens, Camilla, Andrade, Raúl J., Lucena, M. Isabel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992729/ https://www.ncbi.nlm.nih.gov/pubmed/27597831 http://dx.doi.org/10.3389/fphar.2016.00267

Ejemplares similares

Genetic variations in drug-induced liver injury (DILI): resolving the puzzle
por: Stephens, Camilla, et al.
Publicado: (2012)

Nitrofurantoin-induced liver injury: long-term follow-up in two prospective DILI registries
por: Bessone, Fernando, et al.
Publicado: (2022)

A new framework for advancing in drug‐induced liver injury research. The Prospective European DILI Registry
por: Björnsson, Einar S., et al.
Publicado: (2022)

Killer Immunoglobulin-Like Receptor Profiles Are not Associated with Risk of Amoxicillin-Clavulanate–Induced Liver Injury in Spanish Patients
por: Stephens, Camilla, et al.
Publicado: (2016)

Mechanistic Studies of Idiosyncratic DILI: Clinical Implications
por: Uetrecht, Jack
Publicado: (2019)

The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic Initiative
por: Bessone, Fernando, et al.
Publicado: (2016)

Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice
por: Villanueva-Paz, Marina, et al.
Publicado: (2021)

Setting up criteria for drug‐induced autoimmune‐like hepatitis through a systematic analysis of published reports
por: Björnsson, Einar S., et al.
Publicado: (2022)

Hepatotoxicity by Dietary Supplements: A Tabular Listing and Clinical Characteristics
por: García-Cortés, Miren, et al.
Publicado: (2016)

Trends in Qualifying Biomarkers in Drug Safety. Consensus of the 2011 Meeting of the Spanish Society of Clinical Pharmacology
por: Agúndez, José A. G., et al.
Publicado: (2012)

Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction
por: Segovia-Zafra, Antonio, et al.
Publicado: (2021)

Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019
por: Teschke, Rolf
Publicado: (2019)

The DILI‐sim Initiative: Insights into Hepatotoxicity Mechanisms and Biomarker Interpretation
por: Watkins, Paul B.
Publicado: (2019)

The Promise of AI for DILI Prediction
por: Vall, Andreu, et al.
Publicado: (2021)

Therapeutic Management of Idiosyncratic Drug-Induced Liver Injury and Acetaminophen Hepatotoxicity in the Paediatric Population: A Systematic Review
por: Niu, Hao, et al.
Publicado: (2022)

Serum apolipoprotein A1 and haptoglobin, in patients with suspected drug-induced liver injury (DILI) as biomarkers of recovery
por: Peta, Valentina, et al.
Publicado: (2017)

Critical Review of Gaps in the Diagnosis and Management of Drug-Induced Liver Injury Associated with Severe Cutaneous Adverse Reactions
por: Villanueva-Paz, Marina, et al.
Publicado: (2021)

One step forward in health promotion
por: Rosu, M
Publicado: (2012)

One step forward to personalized medicine?
por: Dodge, Hiroko H., et al.
Publicado: (2023)

Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials
por: Hey-Hadavi, Juliana, et al.
Publicado: (2021)

Next‐Generation DILI Biomarkers: Prioritization of Biomarkers for Qualification and Best Practices for Biospecimen Collection in Drug Development
por: Roth, Sharin E., et al.
Publicado: (2019)

Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes
por: Quintás, Guillermo, et al.
Publicado: (2021)

One more year and looking forward
por: Karlsson, Jon, et al.
Publicado: (2021)

Tocilizumab in COVID-19: Factors Associated With Mortality Before and After Treatment
por: Sarabia De Ardanaz, Luis, et al.
Publicado: (2021)

Virus Taxonomy: One Step Forward, Two Steps Back
por: Eberhard, Mark
Publicado: (2004)

The Science of Ageism: Two Steps Forward, One Step Back
por: Lee, Jerin, et al.
Publicado: (2020)

Microphysiological Models for Mechanistic-Based Prediction of Idiosyncratic DILI
por: Stern, Sydney, et al.
Publicado: (2023)

N-Acetylcysteine for Preventing Acetaminophen-Induced Liver Injury: A Comprehensive Review
por: Licata, Anna, et al.
Publicado: (2022)

One step forward, one step sideways? Expanding research capacity for neglected diseases
por: Lexchin, Joel
Publicado: (2010)

Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver Injury
por: Ortega-Alonso, Aida, et al.
Publicado: (2016)

N-Acetylcysteine for the Management of Non-Acetaminophen Drug-Induced Liver Injury in Adults: A Systematic Review
por: Sanabria-Cabrera, Judith, et al.
Publicado: (2022)

Selected ABCB1, ABCB4 and ABCC2 Polymorphisms Do Not Enhance the Risk of Drug-Induced Hepatotoxicity in a Spanish Cohort
por: Ulzurrun, Eugenia, et al.
Publicado: (2014)

Correction: Selected ABCB1, ABCB4 and ABCC2 Polymorphisms Do Not Enhance the Risk of Drug-Induced Hepatotoxicity in a Spanish Cohort
por: Ulzurrun, Eugenia, et al.
Publicado: (2015)

One Step Forward, Two Steps Back: Bronchial Thermoplasty for Asthma
por: Krishnan, Jerry A., et al.
Publicado: (2021)

Editorial: Therapeutic strategies for drug-induced liver injury: Review of the current literature
por: Robles-Díaz, Mercedes, et al.
Publicado: (2022)

Factors limiting immunization coverage in urban Dili, Timor-Leste
por: Amin, Ruhul, et al.
Publicado: (2013)

Clinical management of patients with drug‐induced liver injury (DILI)
por: Björnsson, Einar S.
Publicado: (2021)

Landscape of DILI-related adverse drug reaction in China Mainland
por: Wang, Jiabo, et al.
Publicado: (2022)

Cough Hypersensitivity Syndrome: A Few More Steps Forward
por: Song, Woo-Jung, et al.
Publicado: (2017)

Role of Corticosteroids in Drug-Induced Liver Injury. A Systematic Review
por: Björnsson, Einar S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hsj48pok3p9a20pb8e3klb8e58